USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cellmax Technologies AB

USPTO PatentsView assignee record - 17 granted patents across 3 technology areas, active 2015–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H01Q (ANTENNAS, i.e. RADIO AERIALS).

17
Total patents granted
3
CPC technology areas
20.0
Avg claims per patent
-11%
5-year filing velocity

The verdict

Cellmax holds 17 US patents across 3 technology areas, rank #16,668 of 50,000 tracked assignees.

#16,668
of 50,000 US assignees by volume
Top 69%
by Innovation Score (29.4/100)
20.0
avg claims per patent
-11%
filing velocity, last 5 yrs

Portfolio overview

CELLMAX TECHNOLOGIES AB has been granted 17 US utility patents between 2015 and 2023, placing CELLMAX TECHNOLOGIES AB at rank #16,668 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.0 claims per patent with primary concentration in H01Q (ANTENNAS, i.e. RADIO AERIALS). As a Foreign Corporation, CELLMAX TECHNOLOGIES AB is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 29.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 8 grants, compared with 9 in the 2015–2019 window, a -11% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. CELLMAX TECHNOLOGIES AB's 20.0 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark CELLMAX TECHNOLOGIES AB against peers pursuing similar technology classes.

How does CELLMAX compare?

Granted US patents 2015–2025 versus the largest corporate holders, this company marked ◀

patents

What this shows CELLMAX holds 17 patents, placing it at rank #16,668 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView, granted utility patents As of 2015–2025

CELLMAX's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

29 Top 69% higher than 31% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). This entry sits in this band. 30–40: 15,294 US assignees (31%). Above this entry. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

012345 20152016201720182019202020212023 2
USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
CELLMAX TECHNOLOGIES AB patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 11.8%
2016 1 5.9%
2017 1 5.9%
2018 1 5.9%
2019 4 23.5%
2020 3 17.6%
2021 3 17.6%
2023 2 11.8%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Complex
Velocity Declining

Where it ranks

Overall rank by patents

#16,668

Across all tracked assignees

Innovation Score

29.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does CELLMAX TECHNOLOGIES AB hold?
CELLMAX TECHNOLOGIES AB holds 17 US granted patents filed between 2015 and 2023, spanning 3 technology areas.
What is CELLMAX TECHNOLOGIES AB's Innovation Score?
CELLMAX TECHNOLOGIES AB has an Innovation Score of 29.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does CELLMAX TECHNOLOGIES AB focus on?
CELLMAX TECHNOLOGIES AB's top technology area is H01Q (ANTENNAS, i.e. RADIO AERIALS) with 17 patents. The company has filed patents in 3 CPC subclasses total.
Is CELLMAX TECHNOLOGIES AB's patent filing rate increasing or decreasing?
CELLMAX TECHNOLOGIES AB's recent filing velocity is -11% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for CELLMAX TECHNOLOGIES AB's patents?
CELLMAX TECHNOLOGIES AB's patents average 20.0 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the CELLMAX TECHNOLOGIES AB patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Guides to patent portfolio analysis

How to use this portfolio

Cellmax's 17 grants land it in the top 69% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Cellmax ranks #16,668 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in H01Q - see who else leads that technology area. H01Q leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov